PolyPid (PYPD) Short-term Investments (2019 - 2026)
PolyPid (PYPD) posted Short-term Investments of $194000.0 for Q1 2026, up 0.52% sequentially from $193000.0 in Q4 2025, and up 17.58% YoY from $165000.0 in Q1 2025.
PolyPid (PYPD) Short-term Investments (2019 - 2026) Analysis & Trends
PolyPid has reported Short-term Investments for 8 years, with the latest figure at $194000.0 in Q1 2026.
- Quarterly Short-term Investments rose 17.58% year-over-year to $194000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $194000.0 (up 17.58% YoY) and the FY2025 annual result came in at $193000.0, up 14.88% from the prior year.
- Short-term Investments climbed to $194000.0 in Q1 2026 per PYPD's latest filing, from $193000.0 in the prior quarter.
- Over five years, Short-term Investments peaked at $576000.0 in Q2 2022 and troughed at $163000.0 in Q2 2024.
- A 5-year average of $309294.1 and a median of $194000.0 in 2026 frame the typical range for Short-term Investments.
- The sharpest annual moves came in 2022 and 2024: Short-term Investments surged 48.45% in 2022, then plunged 67.59% in 2024.
- Over 5 years, Short-term Investments stood at $511000.0 in 2022, then tumbled by 41.29% to $300000.0 in 2023, then slumped by 44.0% to $168000.0 in 2024, then advanced by 14.88% to $193000.0 in 2025, then grew by 0.52% to $194000.0 in 2026.
- According to Business Quant data, Short-term Investments over the past three periods registered $194000.0, $193000.0, and $186000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | PolyPid | 113.86 Mn | 107.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 207,000.00 |
| Mar 31, 2026 | 194,000.00 |
| Dec 31, 2025 | 193,000.00 |
| Sep 30, 2025 | 186,000.00 |
| Jun 30, 2025 | 182,000.00 |
| Mar 31, 2025 | 165,000.00 |
| Dec 31, 2024 | 168,000.00 |
| Sep 30, 2024 | 165,000.00 |
| Jun 30, 2024 | 163,000.00 |
| Mar 31, 2024 | 166,000.00 |
| Dec 31, 2023 | 300,000.00 |
| Sep 30, 2023 | 495,000.00 |
| Jun 30, 2023 | 503,000.00 |
| Mar 31, 2023 | 504,000.00 |
| Dec 31, 2022 | 511,000.00 |
| Sep 30, 2022 | 394,000.00 |
| Jun 30, 2022 | 576,000.00 |
| Mar 31, 2022 | 393,000.00 |
| Dec 31, 2021 | 397,000.00 |
| Sep 30, 2021 | 390,000.00 |